YJ:NASDAQYunji Inc. - American Depository Shares Analysis
Data as of 2026-05-12 - not real-time
$1.87
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Yunji Inc. (YJ) is trading at $1.87, comfortably above its 20‑day (≈$1.81) and 50‑day (≈$1.74) simple moving averages, indicating a short‑term bullish bias. The RSI of 57 suggests momentum is still neutral, while the MACD shows a modest bullish crossover (histogram ≈0.005). Price sits near the upper end of its technical range, with support at $1.55 and resistance at $1.91, and volume is trending downward, hinting at waning buying pressure. Fundamentally, the company is struggling: revenue fell 18% YoY to $317 M, margins are deep in the red (operating margin –27%, profit margin –42%), and cash flow is negative. The balance sheet shows a high debt‑to‑equity ratio of 4.6 and modest cash reserves of $199 M, raising solvency concerns. Valuation metrics are ultra‑low (price‑to‑book 0.07, price‑to‑sales 0.03) but are driven by the current loss situation rather than hidden upside. The market cap is only $9.2 M, making the stock extremely illiquid, and the 30‑day volatility exceeds 75%, reflecting price instability. The Fear & Greed Index at “Extreme Greed” (88.6) may be a contrarian signal given the underlying fundamentals. Overall, the technical picture is mildly positive, but the fundamental and risk profile are markedly negative.
Given the high beta (negative in computed data) and a historic max drawdown of over 50%, investors should treat YJ as a high‑risk play. The Chinese consumer‑cyclical sector faces regulatory headwinds and shifting consumer sentiment, adding to sector and regulatory risk. With no dividend and a precarious cash‑flow outlook, the stock lacks income stability. Unless a clear turnaround strategy materializes, the prudent stance is to stay on the sidelines while monitoring for any substantive operational improvement.
Given the high beta (negative in computed data) and a historic max drawdown of over 50%, investors should treat YJ as a high‑risk play. The Chinese consumer‑cyclical sector faces regulatory headwinds and shifting consumer sentiment, adding to sector and regulatory risk. With no dividend and a precarious cash‑flow outlook, the stock lacks income stability. Unless a clear turnaround strategy materializes, the prudent stance is to stay on the sidelines while monitoring for any substantive operational improvement.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price above short‑term moving averages
- Decreasing volume trend
- Negative earnings and cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Continued revenue decline
- Ultra‑low valuation multiples
- High debt‑to‑equity ratio
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Sustained negative profitability
- Elevated volatility and drawdown
- Regulatory and geopolitical exposure in China
Key Metrics & Analysis
Financial Health
Revenue Growth-18.30%
Profit Margin-42.04%
P/E Ratio18.7
ROE-13.24%
ROA-7.00%
Debt/Equity4.61
P/B Ratio0.1
Op. Cash Flow$-57780000
Free Cash Flow$-58914124
Technical Analysis
TrendBullish
RSI57.2
Support$1.55
Resistance$1.91
MA 20$1.81
MA 50$1.74
MA 200$1.67
MACDBullish
VolumeDecreasing
Fear & Greed Index88.61
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta-0.59
Volatility76.94%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
ZKH
ZKH Group Limited
STOCKZJYL
JIN MEDICAL INTERNATIONAL LTD.
STOCKZJK
ZJK Industrial Co., Ltd.
STOCKZIP
ZipRecruiter, Inc.
STOCKZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.